WM

Summary

Our analysis maintains a Sell/reduce stance on WM, favoring staged de-risking near current levels and scaling out on bounces toward short-term moving averages and the mid-Bollinger band rather than chasing breakdowns at support. We favor trimming longs in tranches and avoiding new outright shorts at 38.4% implied volatility, using defined-risk hedges for any core holding. Invalidation is a daily close above the 200-day moving average on volume. We would pause selling if the lower Bollinger band holds on close with RSI divergence and MACD histogram contraction. Horizon is 5-7 trading days, with proceeds redeployed to cleaner balance sheets and cash rather than high-beta semis in the current fear regime.

The case

Our analysis supports a Sell on WM based on four converging factors.

1) Technical breakdown and failed rally: price remains below key short- and long-term moving averages with the volume-weighted average price above price confirming distribution, while MACD remains bearish and RSI is bearish with room to further downside. The 8.6% drop from the recent peak occurred with no bullish divergence, and a 6.5% drift post-earnings despite Q2 revenue re-acceleration of 7.3% QoQ shows good news failing to lift price, indicating multiple compression.

2) Valuation offers no cushion: elevated multiples on earnings and book with a high PEG and only a 2.68% free cash flow yield leave little downside protection.

3) Leverage elevates risk in the current fear regime: high debt-to-equity, elevated net debt relative to EBITDA, a weak current ratio, negative tangible book, and 38% of assets in goodwill and intangibles leave the balance sheet vulnerable to de-rating.

4) Hedging demand and execution discipline: implied volatility at 38.4% reflects paying up for downside protection with elevated put/call skew, while the 6 vs 3 bullish tilt on social sentiment channels on a small sample is thin noise. Selling into stretched support near the lower Bollinger band risks whipsaw on partial volume, so staged de-risking captures trend and leverage downside without chasing lows at elevated volatility. Solid Q2 free cash flow and operating cash flow mitigate near-term solvency but do not offset valuation risk.

What would weaken it

• Stretched support near lower Bollinger risks whipsaw on low volume
• High leverage and 38% goodwill/intangibles vulnerable in fear regime
• Elevated 38.4% IV raises hedging cost; valuation offers no cushion